Clinical Trials Browser

INDUSTRY × Lymphoma, Follicular × abexinostat × Clear all

Lymphoma, Follicular, Neoplasms

NCT03934567 2025-04-10

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 2 Active not recruiting

87 enrolled

Lymphoid

Lymphoma, Follicular, Recurrence

NCT00724984 2014-04-07

PCYC-0403

Phase 1/2 Completed

55 enrolled 11 charts

DermatologicLymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

FORERUNNER

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

PCYC-0403